Preliminary research suggest conolidine could inhibit distinct ion channels, minimizing neuronal excitability and limiting soreness alerts. This mechanism is especially relevant in neuropathic suffering, where by irregular signaling triggers persistent discomfort. On top of that, conolidine appears to impact G protein-coupled receptor (GPCR) pathwa